Immunofluorescence microscopy | HeLa cells were treated with indicated compounds at their respective EC90 for 20 hours, fixed with 4% parafor-maldehyde, permeabilized with 0.2% Triton X- 100/ PBS and co-stained for DNA (0.5 ug/ ml Hoechst 33342) and tubulin (rat anti-tubulin primary antibodies and anti-rat Cy3 secondary antibodies). |
Relating network connectivity to consensus drug mechanism | Consistently, a similar SAR trend was observed by evaluating each compound’s potency (EC50) in HeLa cells with regards to their ability to arrest cells in G2/M-phase and induce cell death. |
Relating network connectivity to consensus drug mechanism | To test if tubulin was the primary target, we treated HeLa cells with compounds 6—12 and analyzed their effects by IF microscopy. |
Relating network connectivity to consensus drug mechanism | As expected, compounds 6—12 induced a microtubule depolymerization phenotype in HeLa cells (Figs 5G and 812). |
Supporting Information | (AF) Immunofluorescence of HeLa cells treated with control DMSO or indicated compounds (1—5) for 20 hours. |
Supporting Information | (A) For cell Viability assays, HeLa cells were treated with increasing concentrations (20-point titration 0—-100 uM) of indicated compounds (6—12) for 20 hours and the percentage of cells arrested in G2/M was quantified. |
Supporting Information | Immunofluorescence microscopy of HeLa cells treated with control DMSO, Taxol, col-chicine, or the indicated compounds (6—12) for 20 hours. |